Drug General Information
Drug ID
D02HWL
Former ID
DIB020602
Drug Name
oleoyl-lysophosphatidylcholine
Synonyms
lysolecithin; LPC 18:1; lysophosphatidylcholine(18:1); OLPC
Drug Type
Small molecular drug
Indication Discovery agent Investigative [540484]
Structure
Download
2D MOL
Formula
C26H52NO7P
InChI
InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1
InChIKey
YAMUFBLWGFFICM-PTGWMXDISA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Glucose-dependent insulinotropic receptor Target Info Agonist [527346]
KEGG Pathway cAMP signaling pathway
Insulin secretion
WikiPathways Incretin Synthesis, Secretion, and Inactivation
References
Ref 540484(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3623).
Ref 527346Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun. 2005 Jan 28;326(4):744-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.